Welcome to the CJU website » LOG IN


Remission of hormone-refractory prostate cancer attributed to Essiac
Division of Urology, The Princess Margaret Hospital, University of Toronto, Toro
Oct 2005 (Vol. 12, Issue 5, Pages( 2841 - 2842)


Text-Size + 

  • Essiac is a popular complementary and alternative medicine (CAM) that is utilized by many cancer patients in North America. Much anecdotal reporting exists about its cancer-fighting qualities, but so far no clinical trials have been preformed to validate those claims. We describe here the case of a 64-year-old man whose hormone-refractory prostate cancer responded well to Essiac tea.

Current Issue

August 2021, Vol.28 No.4
canadian journal of urology